Evidence map›Paper›PMID 38672475›Full record

ReviewBiomolecules2024

Applications of Exosomal miRNAs from Mesenchymal Stem Cells as Skin Boosters.

Jinmei Zheng, Beibei Yang, Siqi Liu, Zhenfeng Xu, Zhimeng Ding, Miaohua Mo

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jinmei ZhengDepartment of Biotechnology, Guangdong Medical University, Dongguan 523808, China.ORCID 0009-0004-6241-6105
Beibei YangDepartment of Biotechnology, Guangdong Medical University, Dongguan 523808, China.ORCID 0009-0004-9253-3927
Siqi LiuDepartment of Biotechnology, Guangdong Medical University, Dongguan 523808, China.ORCID 0009-0001-1557-0669
Zhenfeng XuDepartment of Biotechnology, Guangdong Medical University, Dongguan 523808, China.ORCID 0009-0003-2050-1937
Zhimeng DingDepartment of Biotechnology, Guangdong Medical University, Dongguan 523808, China.ORCID 0009-0009-1277-9983
Miaohua MoDepartment of Biotechnology, Guangdong Medical University, Dongguan 523808, China.
Guangdong Medical College · CN

Funding

Dongguan Science and Technology of Social Development Program 20221800905572Funds for PhD Researchers of Guangdong Medical University GDMUB2021024Guangdong Basic and Applied Basic Research Foundation 2022A1515011696National Natural Science Foundation of China 81903239
6 · The paper itself

Abstract

The skin is the outer layer of the human body, and it is crucial in defending against injuries and damage. The regenerative capacity of aging and damaged skin caused by exposure to external stimuli is significantly impaired. Currently, the rise in average life expectancy and the modern population's aesthetic standards have sparked a desire for stem-cell-based therapies that can address skin health conditions. In recent years, mesenchymal stem cells (MSCs) as therapeutic agents have provided a promising and effective alternative for managing skin regeneration and rejuvenation, attributing to their healing capacities that can be applied to damaged and aged skin. However, it has been established that the therapeutic effects of MSC may be primarily mediated by paracrine mechanisms, particularly the release of exosomes (Exos). Exosomes are nanoscale extracellular vesicles (EVs) that have lipid bilayer and membrane structures and can be naturally released by different types of cells. They influence the physiological and pathological processes of recipient cells by transferring a variety of bioactive molecules, including lipids, proteins, and nucleic acids such as messenger RNAs (mRNAs) and microRNAs (miRNAs) between cells, thus playing an important role in intercellular communication and activating signaling pathways in target cells. Among them, miRNAs, a type of endogenous regulatory non-coding RNA, are often incorporated into exosomes as important signaling molecules regulating protein biosynthesis. Emerging evidence suggests that exosomal miRNAs from MSC play a key role in skin regeneration and rejuvenation by targeting multiple genes and regulating various biological processes, such as participating in inflammatory responses, cell migration, proliferation, and apoptosis. In this review, we summarize the recent studies and observations on how MSC-derived exosomal miRNAs contribute to the regeneration and rejuvenation of skin tissue, with particular attention to the applications of bioengineering methods for manipulating the miRNA content of exosome cargo to improve their therapeutic potential. This review can provide new clues for the diagnosis and treatment of skin damage and aging, as well as assist investigators in exploring innovative therapeutic strategies for treating a multitude of skin problems with the aim of delaying skin aging, promoting skin regeneration, and maintaining healthy skin.

Indexed as

ExosomesMesenchymal Stem CellsMicroRNAsSkinAnimalsHumansMesenchymal Stem Cell TransplantationRegenerationMicroRNAsbioengineering approachesexosomesmesenchymal stem cellsmiRNAsskin regeneration and rejuvenation

Identifiers

PMID38672475
PMCPMC11048182
OpenAlexW4394603889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.